Forte Biosciences Stock Probability Of Bankruptcy

FBRX Stock  USD 0.70  0.01  1.45%   
Forte Biosciences' chance of distress is above 80% at this time. It has very high odds of going through financial hardship in the upcoming years. Chance Of Bankruptcy shows the probability of financial distress over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Forte balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Forte Biosciences Piotroski F Score and Forte Biosciences Altman Z Score analysis.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
  

Forte Probability Of Bankruptcy Analysis

Forte Biosciences' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
 2023 2024 (projected)
Short and Long Term Debt Total7.9M13.5M
Total Assets39.0M43.2M

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Forte Biosciences Probability Of Bankruptcy

    
  Over 82%  
Most of Forte Biosciences' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Forte Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Forte Biosciences probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Forte Biosciences odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Forte Biosciences financial health.
Is Forte Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.00)
Return On Assets
(0.50)
Return On Equity
(0.85)
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Forte Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Forte Biosciences is extremely important. It helps to project a fair market value of Forte Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Forte Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Forte Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Forte Biosciences' interrelated accounts and indicators.
0.550.83-0.06-0.740.570.32-0.380.83-0.38-0.150.680.80.61.00.240.70.61-0.1-0.24-0.28-0.35-0.260.38
0.550.130.35-0.810.740.62-0.450.47-0.45-0.290.70.680.820.52-0.070.770.69-0.11-0.53-0.54-0.45-0.530.43
0.830.13-0.49-0.530.24-0.15-0.220.54-0.220.170.340.60.060.850.510.350.17-0.170.250.230.080.24-0.01
-0.060.35-0.49-0.060.040.77-0.40.42-0.4-0.790.57-0.020.6-0.08-0.260.040.690.47-0.82-0.83-0.53-0.830.5
-0.74-0.81-0.53-0.06-0.73-0.270.32-0.530.320.0-0.72-0.88-0.57-0.73-0.47-0.77-0.490.340.210.240.050.24-0.04
0.570.740.240.04-0.730.190.00.320.00.220.480.640.70.550.090.960.33-0.59-0.35-0.36-0.27-0.350.32
0.320.62-0.150.77-0.270.19-0.420.64-0.42-0.870.630.380.810.3-0.390.310.880.44-0.72-0.75-0.69-0.740.65
-0.38-0.45-0.22-0.40.320.0-0.42-0.561.00.58-0.62-0.05-0.38-0.390.14-0.03-0.68-0.620.580.550.570.54-0.51
0.830.470.540.42-0.530.320.64-0.56-0.56-0.610.810.590.720.830.070.480.870.28-0.61-0.63-0.6-0.620.55
-0.38-0.45-0.22-0.40.320.0-0.421.0-0.560.58-0.62-0.05-0.38-0.390.14-0.03-0.68-0.620.580.550.570.54-0.51
-0.15-0.290.17-0.790.00.22-0.870.58-0.610.58-0.5-0.06-0.51-0.130.330.11-0.78-0.710.650.650.630.64-0.58
0.680.70.340.57-0.720.480.63-0.620.81-0.62-0.50.620.760.680.160.520.870.25-0.64-0.7-0.42-0.70.47
0.80.680.6-0.02-0.880.640.38-0.050.59-0.05-0.060.620.580.790.40.760.48-0.34-0.07-0.13-0.02-0.140.04
0.60.820.060.6-0.570.70.81-0.380.72-0.38-0.510.760.580.57-0.280.770.870.05-0.81-0.83-0.75-0.830.71
1.00.520.85-0.08-0.730.550.3-0.390.83-0.39-0.130.680.790.570.250.680.6-0.09-0.23-0.26-0.34-0.250.37
0.24-0.070.51-0.26-0.470.09-0.390.140.070.140.330.160.4-0.280.250.07-0.23-0.450.430.430.680.41-0.59
0.70.770.350.04-0.770.960.31-0.030.48-0.030.110.520.760.770.680.070.44-0.54-0.37-0.38-0.35-0.380.33
0.610.690.170.69-0.490.330.88-0.680.87-0.68-0.780.870.480.870.6-0.230.440.46-0.81-0.84-0.74-0.830.71
-0.1-0.11-0.170.470.34-0.590.44-0.620.28-0.62-0.710.25-0.340.05-0.09-0.45-0.540.46-0.38-0.41-0.4-0.410.37
-0.24-0.530.25-0.820.21-0.35-0.720.58-0.610.580.65-0.64-0.07-0.81-0.230.43-0.37-0.81-0.380.990.840.98-0.72
-0.28-0.540.23-0.830.24-0.36-0.750.55-0.630.550.65-0.7-0.13-0.83-0.260.43-0.38-0.84-0.410.990.811.0-0.71
-0.35-0.450.08-0.530.05-0.27-0.690.57-0.60.570.63-0.42-0.02-0.75-0.340.68-0.35-0.74-0.40.840.810.78-0.89
-0.26-0.530.24-0.830.24-0.35-0.740.54-0.620.540.64-0.7-0.14-0.83-0.250.41-0.38-0.83-0.410.981.00.78-0.68
0.380.43-0.010.5-0.040.320.65-0.510.55-0.51-0.580.470.040.710.37-0.590.330.710.37-0.72-0.71-0.89-0.68
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Forte Biosciences has a Probability Of Bankruptcy of 82%. This is 89.42% higher than that of the Biotechnology sector and 49.53% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 105.87% lower than that of the firm.

Forte Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Forte Biosciences' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Forte Biosciences could also be used in its relative valuation, which is a method of valuing Forte Biosciences by comparing valuation metrics of similar companies.
Forte Biosciences is currently under evaluation in probability of bankruptcy category among related companies.

Forte Biosciences Main Bankruptcy Drivers

201920202021202220232024 (projected)
Return On Assets(0.53)(1.28)(0.5)(0.33)(0.81)(0.85)
Net Debt1.8M(58.8M)(42.0M)(41.1M)(12.0M)(12.6M)
Total Current Liabilities1.9M2.3M1.8M3.2M3.7M6.0M
Non Current Liabilities Total28.4M10.5M1.2M946K1.2M0.0
Total Assets7.7M61.2M43.3M42.0M39.0M43.2M
Total Current Assets7.5M59.9M42.5M41.5M38.3M41.8M
Total Cash From Operating Activities(2.8M)(18.4M)(16.7M)(8.2M)(28.7M)(30.1M)

Forte Fundamentals

About Forte Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Forte Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Forte Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Forte Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. Forte Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Forte Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Forte Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Forte Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Forte Biosciences Stock:
Check out Forte Biosciences Piotroski F Score and Forte Biosciences Altman Z Score analysis.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Forte Stock analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Forte Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.00)
Return On Assets
(0.50)
Return On Equity
(0.85)
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.